🤔
$Recursion Pharmaceuticals (RXRX.US)$Do you think recursion pharmaceuticals falls within the vision of President Trump?
and if you do what do you think's going to happen when they announce some significant relevant news do you think at some point in time you're going to have a stock that's going to go from $4 to zero or do you think under this vision of President Trump the people are going to start to Target companies that are utilizing artificial intelligence in the lab for science for medical for healthcare to have these massive breakthroughs that are going to change the world and if that were to happen can you imagine how much money is going to flow into this stock from every mutual fund every ETF every retail investor
just think about that from a risk reward standpoint do you think we've got most of the downside priced in?
The goal of Project Genesis, which President Trump signed into an executive order yesterday, is to create a unified federal AI platform that leverages the nation’s largest collection of scientific data to accelerate scientific discovery, bolster national security, and boost technological progress. This initiative aims to combine the expertise of American scientists, national laboratories, private sector businesses, and universities to rapidly advance AI development and its application in solving engineering, energy, and national security challenges. The project also includes creating a digital infrastructure called the American Science and Security Platform to provide computational resources and datasets for training AI models that can automate research, test hypotheses, and expedite innovation across multiple fields such as biotechnology, advanced manufacturing, quantum science, and energy technologies. Essentially, Project Genesis is designed as an ambitious, nation-wide AI-driven scientific effort comparable in urgency to the Manhattan Project, focusing on fostering U.S. technological dominance and economic growth through AI
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
37+ yrs in the trenches, raised 100mil for start ups, syndicate ipo's, yrs on trading desk
opinion not financial advice
9426
Followers
61
Following
133K
Visitors
Follow
Market Insights
Hot Topics Hot Topics
The Week Kicks Off: Bank Earnings, CPI Data, and Possible Action on Iran
This week brings a triple threat for markets: major bank earnings, crucial inflation data that could alter Fed policy, and rising geopolitic
In One Chart
Dec 1, 2025 13:36
December's Must-See Financial Events: FOMC Meeting, Jobs and Inflation Data, Santa Claus Rally, and More
Moomoo Insights
Dec 24, 2025 22:09
U.S. E-commerce vs. Traditional Retailers: Is a Battle Inevitable? A Comparison of Amazon and Walmart
Player-456 : Smart money already positioned themselves in these AI/biotech stocks before Project Genesis . AI playoffs from picks & shovels to infrastructure & now to applications, I think.
2026 will be big for AI application in drug discovery. RXRX is one of the hot plays.
10baggerbamm OP Player-456 : I don't necessarily agree that smart money is already positioned itself because if it did you would see these breakout names listed you would have already seen a significant move higher in these companies and they already would be chatted about and talked about and when you do a perplexity search or similar of the companies that will be benefiting directly from this project there's very few company names listed aside from the obvious
VicVegas007 : This article brings up some good points. What the administration has not provided is just as striking: no public cost estimate, no explicit appropriation, and no breakdown of who will pay for what. Major news outlets including Reuters, Associated Press, Politico, and others have all noted that the order “does not specify new spending or a budget request,” or that funding will depend on future appropriations and previously passed legislation.
That omission, combined with the initiative’s scope and timing, raises questions not only about how Genesis will be funded and to what extent, but about who it might quietly benefit.
Soon after DOE promoted the mission on X, Teknium of the small U.S. AI lab Nous Research posted a blunt reaction: “So is this just a subsidy for big labs or what.”
The aggressive DOE deadlines and the order’s requirement to build a national AI compute-and-experimentation stack amplify those questions: the government is now constructing something strikingly similar to what private labs have been spending billions to build for themselves.
venturebeat.com...
It's a good read, asks alot if questions that still need to be answered
Player-456 10baggerbamm OP : Some funds are obviously in . You can see some AI health n biotech stocks prices were firm last week & even up when the mkt was sold down with fears of AI bubble . They are starting to rotate in . More to come next year
10baggerbamm OP Player-456 : the home Market had a balance and the reality is is biotech stocks have been one of the top performers over the past 90 days you can look at any ETF any index and they just busted another all-time high yesterday. we had a bounce in the market of course lower price stocks bounced as well the point is you can do a search all you want with perplexity or chat EPT there is no winner list that has been selected of AI research biotech companies that are endowed by project Gemini so again the market bounce stocks went up but there is no physical list of companies that are known benefactors there's only speculation in guessing right now